Table 2.
Quality assessment of individual studies
Study | Study design | Spectrum biasa | Eligibility criteria clearly defined | Appropriate reference standard | Differential verification biasb | Index test and reference standard sufficiently described | Selective loss during followupc | Important confounders identified |
---|---|---|---|---|---|---|---|---|
Zheng et al. [6] | Prospective study | No | Yes | Yes | Yes | Yes | No | Yes |
Sirota et al. [7] | Retrospective and prospective study | No | Yes | Yes | Yes | Yes | – | Yes |
Li et al. [11] | Prospective study | No | Yes | Yes | Yes | Yes | No | Yes |
Chen et al. [12] | Prospective study | No | No | Yes | Yes | Yes | No | Yes |
Parikh et al. [13] | Prospective, multicenter cohort study | No | Yes | Yes | Yes | Yes | No | Yes |
Parikh et al. [14] | Prospective, multicenter cohort study | No | Yes | Yes | Yes | Yes | No | Yes |
Endre et al. [15] | Prospective observational study | No | Yes | Yes | Yes | Yes | No | Yes |
Liangos et al. [16] | Prospective cohort study | No | Yes | Yes | Yes | Yes | No | Yes |
Washburn et al. [17] | Prospective study | No | Yes | Yes | Yes | Yes | No | Yes |
Parikh et al. [18] | Prospective study | No | Yes | Yes | Yes | Yes | No | Yes |
Parikh et al. [19] | Prospective study | No | Yes | Yes | Yes | Yes | No | Yes |
aThis item is labeled “No” if the spectrum of patients was representative of patients who received the test in practice, otherwise it is labeled “Yes”
bThis item is labeled “No” when all patients received the same reference standard, otherwise it is labeled “Yes”
cThis item is labeled “Yes” if patients who were lost to follow-up differed systematically from those who remained, otherwise it is labeled “No”
“—” This item is not applicable if the study was retrospective in design